The company still needs shareholder approval to follow through on its plan to shutter operations and lay off most of its staff.
https://www.bizjournals.com/washington/news/2023/12/26/neximmune-liquidation-biotech-shareholder-vote.html
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.